Ironwood Investment Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $744K | Buy |
53,212
+3,907
| +8% | +$54.7K | 0.36% | 85 |
|
2025
Q1 | $670K | Buy |
49,305
+12,759
| +35% | +$173K | 0.37% | 83 |
|
2024
Q4 | $745K | Sell |
36,546
-38
| -0.1% | -$774 | 0.37% | 83 |
|
2024
Q3 | $1.07M | Buy |
36,584
+355
| +1% | +$10.3K | 0.52% | 65 |
|
2024
Q2 | $841K | Buy |
36,229
+165
| +0.5% | +$3.83K | 0.45% | 73 |
|
2024
Q1 | $740K | Buy |
36,064
+18,126
| +101% | +$372K | 0.36% | 83 |
|
2023
Q4 | $385K | Sell |
17,938
-158
| -0.9% | -$3.39K | 0.2% | 112 |
|
2023
Q3 | $373K | Sell |
18,096
-623
| -3% | -$12.9K | 0.23% | 104 |
|
2023
Q2 | $552K | Sell |
18,719
-77
| -0.4% | -$2.27K | 0.32% | 88 |
|
2023
Q1 | $433K | Sell |
18,796
-353
| -2% | -$8.13K | 0.27% | 105 |
|
2022
Q4 | $533K | Sell |
19,149
-759
| -4% | -$21.1K | 0.35% | 90 |
|
2022
Q3 | $611K | Buy |
19,908
+52
| +0.3% | +$1.6K | 0.43% | 86 |
|
2022
Q2 | $584K | Buy |
19,856
+14
| +0.1% | +$412 | 0.39% | 90 |
|
2022
Q1 | $638K | Buy |
19,842
+459
| +2% | +$14.8K | 0.35% | 99 |
|
2021
Q4 | $864K | Buy |
19,383
+290
| +2% | +$12.9K | 0.43% | 79 |
|
2021
Q3 | $963K | Buy |
19,093
+19
| +0.1% | +$958 | 0.5% | 68 |
|
2021
Q2 | $1.5M | Sell |
19,074
-446
| -2% | -$35K | 0.76% | 38 |
|
2021
Q1 | $1.12M | Buy |
19,520
+155
| +0.8% | +$8.85K | 0.59% | 62 |
|
2020
Q4 | $1.62M | Sell |
19,365
-553
| -3% | -$46.3K | 0.95% | 28 |
|
2020
Q3 | $714K | Sell |
19,918
-40
| -0.2% | -$1.43K | 0.51% | 78 |
|
2020
Q2 | $483K | Sell |
19,958
-112
| -0.6% | -$2.71K | 0.38% | 100 |
|
2020
Q1 | $351K | Sell |
20,070
-741
| -4% | -$13K | 0.35% | 104 |
|
2019
Q4 | $363K | Sell |
20,811
-1,696
| -8% | -$29.6K | 0.25% | 121 |
|
2019
Q3 | $345K | Sell |
22,507
-88
| -0.4% | -$1.35K | 0.26% | 119 |
|
2019
Q2 | $469K | Sell |
22,595
-12
| -0.1% | -$249 | 0.37% | 101 |
|
2019
Q1 | $525K | Buy |
22,607
+12,515
| +124% | +$291K | 0.43% | 89 |
|
2018
Q4 | $209K | Buy |
+10,092
| New | +$209K | 0.19% | 137 |
|